SRRK — Scholar Rock Holding Share News
0.000.00%
Last trade - 00:00Scholar Rock withdraws Europe filing for muscle weakness drug, plans resubmission
Brief: Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Corrected: Scholar Rock drops Novo Nordisk facility from marketing application for muscle weakness drug
U.S. STOCKS ON THE MOVE-Braveheart Bio, Paysign, Hertz Global
Scholar Rock gains after smaller Q2 net loss; FDA review progresses
U.S. STOCKS ON THE MOVE-Ralph Lauren, Sempra, Parker-Hannifin, Lincoln International
Scholar Rock Holding Corporation reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE- MACOM Technology , Becton Dickinson, Centrus Energy
Scholar Rock gains on smaller Q2 net loss; FDA review progresses
Scholar Rock Q2 net loss narrows
Brief: \tScholar Rock Holding Scholar Rock Holding Q2 Net Income USD -109.896 Million
Corrected: Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Scholar Rock Q1 net loss widens as expenses rise
Brief: Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)